Literature DB >> 14672549

A pig model of high altitude pulmonary edema.

Axel Kleinsasser1, David L Levin, Alex Loeckinger, Susan R Hopkins.   

Abstract

High altitude pulmonary edema (HAPE) affects unacclimatized individuals ascending rapidly to high altitude. The pathogenesis of HAPE is not fully elucidated, and many investigative techniques that could provide valuable information are not suitable for use in humans; thus, an animal model is desirable. Rabbits, sheep, dogs, and ferrets have been shown not to consistently develop HAPE, and studies in rats are limited by the animal's small size and inconsistent response. Pigs develop a marked pulmonary vasoconstrictive response to hypoxia, and preliminary studies of HAPE in pigs have been promising. To determine the suitability of pigs as an animal model of HAPE, we exposed six subadult (20 to 25 kg) pigs to normobaric hypoxia (10% oxygen) for 48 hr. One week before, and immediately after exposure to hypoxia, under anesthesia, arterial blood gases were obtained and bronchoalveolar lavage (BAL) and chest x-ray were performed. Hypoxia increased alveolar-arterial pressure difference for oxygen from 22 +/- 9 to 38 +/- 5 torr, p < 0.01) and red cell (from 12.3 +/- 5.9 to 27.4 +/- 5.3 cells x 10(5)/mL(-1), p < 0.001) and white cell (from 1.59 +/- 0.90 to 7.88 +/- 3.36 cells x 10(5)/mL(-1), p < 0.05) concentrations in BAL in all animals. Total BAL protein concentration increased by 64% and fractional albumin by 38% (both p < 0.05) posthypoxia. One animal had evidence of pulmonary edema on X ray. Some pigs develop findings consistent with early HAPE when exposed to normobaric hypoxia. Increasing the duration of hypoxic exposure or exercising the animals in hypoxia may better model the disease process observed in humans with clinically significant HAPE.

Entities:  

Mesh:

Year:  2003        PMID: 14672549     DOI: 10.1089/152702903322616218

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  7 in total

1.  Susceptibility to high-altitude pulmonary edema is associated with a more uniform distribution of regional specific ventilation.

Authors:  Michael D Patz; Rui C Sá; Chantal Darquenne; Ann R Elliott; Amran K Asadi; Rebecca J Theilmann; David J Dubowitz; Erik R Swenson; G Kim Prisk; Susan R Hopkins
Journal:  J Appl Physiol (1985)       Date:  2017-01-05

2.  MDCT-based quantification of porcine pulmonary arterial morphometry and self-similarity of arterial branching geometry.

Authors:  Yik Ching Lee; Alys R Clark; Matthew K Fuld; Susan Haynes; Abhay A Divekar; Eric A Hoffman; Merryn H Tawhai
Journal:  J Appl Physiol (1985)       Date:  2013-02-28

3.  Nogo-B protects mice against lipopolysaccharide-induced acute lung injury.

Authors:  Wujian Xu; Ying Zhu; Yunye Ning; Yuchao Dong; Haidong Huang; Wei Zhang; Qinying Sun; Qiang Li
Journal:  Sci Rep       Date:  2015-07-15       Impact factor: 4.379

4.  Establishment and evaluation of an experimental rat model for high-altitude intestinal barrier injury.

Authors:  Han Luo; Dai-Jun Zhou; Zhang Chen; Qi-Quan Zhou; Kui Wu; Kun Tian; Zhi-Wei Li; Zhen-Liang Xiao
Journal:  Exp Ther Med       Date:  2016-12-29       Impact factor: 2.447

5.  Tolerability of inhaled N-chlorotaurine in the pig model.

Authors:  Ralf Geiger; Benedikt Treml; Anna Pinna; Linn Barnickel; Harald Prossliner; Hannes Reinstadler; Michael Pilch; Maria Hauer; Christoph Walther; Hans-Jörg Steiner; Thomas Giese; Andreas Wemhöner; Sabine Scholl-Bürgi; Waldemar Gottardi; Roland Arnitz; Consolato Sergi; Markus Nagl; Alexander Löckinger
Journal:  BMC Pulm Med       Date:  2009-07-14       Impact factor: 3.317

6.  KGF-2 targets alveolar epithelia and capillary endothelia to reduce high altitude pulmonary oedema in rats.

Authors:  Jun She; Arnaud Goolaerts; Jun Shen; Jing Bi; Lin Tong; Lei Gao; Yuanlin Song; Chunxue Bai
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

7.  Cardiovascular Parameters in a Swine Model of Normobaric Hypoxia Treated With 5-Hydroxymethyl-2-Furfural (5-HMF).

Authors:  Richard Thomas Mahon; Geoffrey E Ciarlone; Nicholas G Roney; Joshua M Swift
Journal:  Front Physiol       Date:  2019-04-18       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.